These results showing that ganetespib stimulates the accumulation of ErbB2+ breast cancer cells in G2/M phase of the cell cycle are consistent with previous reports indicating the anti-proliferative effects of ganetespib in various cancer models. Here, ERBB2 is linked to cancer.